This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Amgen Inc.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Javier O Tapia
Introduction
Javier O Tapia is a notable inventor based in Gurabo, Puerto Rico. He has made significant contributions to the field of medical technology, particularly in the design and functionality of syringe assembly systems. With a total of 3 patents to his name, Tapia continues to push the boundaries of innovation in his field.
Latest Patents
One of Javier O Tapia's latest patents is a "Plunger rod and syringe assembly system and method." This invention involves a machine designed to couple a plunger rod to a syringe assembly. The machine features a carriage that includes a cradle with a seat portion sized to receive a syringe assembly and an aperture portion above the seat portion for the plunger rod. An actuating device is operatively coupled to the carriage, allowing it to move the cradle from a first position to a second position to facilitate the coupling process. The design includes separate and interchangeable carriages, enabling the use of syringe assemblies of different sizes.
Career Highlights
Javier O Tapia has established himself as a key player in the medical technology sector. His work at Amgen Inc. has allowed him to develop innovative solutions that enhance the efficiency and effectiveness of medical devices. His patents reflect a commitment to improving healthcare through technology.
Collaborations
Throughout his career, Tapia has collaborated with talented professionals in the industry, including Jeroen Ketelaars and Lawrence G Leka. These collaborations have contributed to the successful development of his inventions and have fostered a spirit of innovation within his team.
Conclusion
Javier O Tapia's contributions to the field of medical technology are noteworthy. His innovative designs and patents demonstrate his dedication to improving healthcare solutions. As he continues to work at Amgen Inc., his future endeavors are anticipated to further advance the industry.
